Amidation Company Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Amidation Company General Information

Description

Developer of healthcare technology intended to design therapeutic and diagnostic tools for diseases associated with the maturation of amidated peptide hormones. The company offers biomarker-guided diagnostic tools, vascular system targeting therapeutic strategies, GMP production planning, and early clinical development work, enabling doctors and researchers to develop treatments for diseases such as Alzheimer's and dementia.

Contact Information

Website
amidation.de
Formerly Known As
PAM Theragnostics GmbH
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Neuendorfstraße 15B
  • 16761 Hennigsdorf
  • Germany
+49 03302
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • Neuendorfstraße 15B
  • 16761 Hennigsdorf
  • Germany
+49 03302

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amidation Company Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jul-2026 Completed Pre-Clinical Trials
2. Early Stage VC (Series A1) 24-Jan-2022 Completed Pre-Clinical Trials
1. Early Stage VC 01-Jan-2021 Completed Pre-Clinical Trials
To view Amidation Company’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Amidation Company Patents

Amidation Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026099243-A1 Modified and unmodified peptidyl-glycine alpha-amidating monooxygenase (pam) for use in the treatment or prevention of cerebral hypoperfusion for the improvement of cerebral blood flow (cbf) Pending 05-Nov-2024
WO-2026099249-A1 Modified and unmodified peptidylglycine alpha-amidating monooxygenase (pam) for use in subjects having increased amyloid-beta and/or phospho-tau-protein load and/or neuroinflammation Pending 05-Nov-2024
WO-2026046982-A1 A method for the prediction of a risk or severity of side effects in a cancer patient that is to be treated or has been treated with immune effector cell therapy (iect) Pending 26-Aug-2024
US-20260226155-A1 Anti-adm antibodies, anti-adm antibody fragment or anti-adm non-ig scaffold for therapy or prevention of immune effector cell therapy side effects Pending 26-Aug-2024
WO-2026046978-A1 Anti-adm antibodies, anti-adm antibody fragment or anti-adm non-ig scaffold for therapy or prevention of immune effector cell therapy side effects Pending 26-Aug-2024 C07K16/26
To view Amidation Company’s complete patent history, request access »

Amidation Company Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandenburg Kapital Venture Capital Minority
Neuropep GmbH Venture Capital Minority
To view Amidation Company’s complete investors history, request access »

Amidation Company FAQs

  • When was Amidation Company founded?

    Amidation Company was founded in 2020.

  • Where is Amidation Company headquartered?

    Amidation Company is headquartered in Hennigsdorf, Germany.

  • What industry is Amidation Company in?

    Amidation Company’s primary industry is Drug Discovery.

  • Is Amidation Company a private or public company?

    Amidation Company is a Private company.

  • What is Amidation Company’s current revenue?

    The current revenue for Amidation Company is .

  • How much funding has Amidation Company raised over time?

    Amidation Company has raised $1.7M.

  • Who are Amidation Company’s investors?

    Brandenburg Kapital and Neuropep GmbH have invested in Amidation Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process